UniSa - IRIS Institutional Research Information System

BARONE, Paolo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 27.469
NA - Nord America 18.639
EU - Europa 6.495
SA - Sud America 1.163
OC - Oceania 207
AF - Africa 88
Continente sconosciuto - Info sul continente non disponibili 17
Totale 54.078
Salva come PNG Salva come JPEG
Nazione #
HK - Hong Kong 21.777
US - Stati Uniti d'America 18.372
SG - Singapore 2.069
CN - Cina 1.883
IT - Italia 1.428
UA - Ucraina 1.416
BR - Brasile 1.043
RU - Federazione Russa 910
DE - Germania 774
IE - Irlanda 633
VN - Vietnam 576
KR - Corea 412
TR - Turchia 396
SE - Svezia 338
FI - Finlandia 314
GB - Regno Unito 216
CA - Canada 175
EE - Estonia 146
IN - India 113
NZ - Nuova Zelanda 104
AU - Australia 98
NL - Olanda 55
AT - Austria 52
MX - Messico 52
FR - Francia 50
AR - Argentina 45
BD - Bangladesh 40
PL - Polonia 35
JP - Giappone 31
CZ - Repubblica Ceca 28
ES - Italia 28
IQ - Iraq 28
ZA - Sudafrica 21
UZ - Uzbekistan 19
PK - Pakistan 18
EC - Ecuador 17
EU - Europa 16
MA - Marocco 15
IL - Israele 14
AE - Emirati Arabi Uniti 13
CO - Colombia 13
ID - Indonesia 13
VE - Venezuela 12
BE - Belgio 10
CL - Cile 9
EG - Egitto 9
JM - Giamaica 8
KE - Kenya 8
SA - Arabia Saudita 8
LT - Lituania 7
NP - Nepal 7
PE - Perù 7
PY - Paraguay 7
BG - Bulgaria 6
CH - Svizzera 6
IR - Iran 6
AZ - Azerbaigian 5
BO - Bolivia 5
CR - Costa Rica 5
DK - Danimarca 5
DO - Repubblica Dominicana 5
DZ - Algeria 5
ET - Etiopia 5
GR - Grecia 5
JO - Giordania 5
TN - Tunisia 5
UY - Uruguay 5
LU - Lussemburgo 4
PH - Filippine 4
RO - Romania 4
TW - Taiwan 4
CI - Costa d'Avorio 3
KG - Kirghizistan 3
NO - Norvegia 3
OM - Oman 3
PA - Panama 3
PR - Porto Rico 3
PT - Portogallo 3
TJ - Tagikistan 3
AL - Albania 2
AO - Angola 2
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
BS - Bahamas 2
BW - Botswana 2
GT - Guatemala 2
HN - Honduras 2
KH - Cambogia 2
KZ - Kazakistan 2
LV - Lettonia 2
ME - Montenegro 2
MK - Macedonia 2
MN - Mongolia 2
MY - Malesia 2
NI - Nicaragua 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
TH - Thailandia 2
TZ - Tanzania 2
Totale 54.043
Salva come PNG Salva come JPEG
Città #
Hong Kong 21.758
Ann Arbor 4.156
Wilmington 2.250
Jacksonville 1.729
Princeton 1.634
Chandler 1.535
Dallas 907
Singapore 777
Houston 729
Woodbridge 616
Dublin 594
Ashburn 506
Dong Ket 459
Nanjing 399
Andover 368
Izmir 364
Beijing 326
Moscow 312
Boardman 297
Pellezzano 264
Düsseldorf 216
Mestre 203
Naples 149
Tallinn 146
Norwalk 143
Shenyang 134
Fairfield 131
Los Angeles 130
Salerno 122
Hebei 121
Munich 121
Changsha 110
Nanchang 108
Dearborn 107
São Paulo 91
Jiaxing 85
Rome 64
Redwood City 60
New York 56
The Dalles 56
Tianjin 56
Nuremberg 54
San Diego 49
Pune 47
Ho Chi Minh City 45
Auckland 43
Brooklyn 42
Columbus 42
Sydney 42
Milan 37
San Francisco 37
Council Bluffs 35
Turku 35
West Jordan 35
Rio de Janeiro 33
Santa Clara 33
Washington 33
Belo Horizonte 32
Montreal 32
Amsterdam 31
Cambridge 31
Seattle 30
Jinan 29
Casoria 28
Stockholm 28
Ottawa 27
Hanoi 26
Warsaw 25
Boston 24
Brasília 23
Lappeenranta 23
Atlanta 22
London 22
Fort Worth 21
Guangzhou 21
Tokyo 21
Chicago 20
Springfield 19
Venezia 18
Chennai 17
Curitiba 17
Phoenix 17
Shanghai 17
Tashkent 17
Vienna 17
Melbourne 16
Brno 15
Campinas 15
Lecce 14
Toronto 14
Baghdad 13
Hangzhou 13
Porto Alegre 13
Ankara 12
Bologna 12
Brisbane 12
Charlotte 12
Christchurch 12
Hamilton 12
Johannesburg 12
Totale 43.883
Salva come PNG Salva come JPEG
Nome #
Retinal thinning in progressive supranuclear palsy: differences with healthy controls and correlation with clinical variables 1.155
Step length predicts executive dysfunction in Parkinson’s disease: a 3-year prospective study 938
Longitudinal change of energy expenditure, body composition and dietary habits in Progressive Supranuclear Palsy patients 901
Managing Device-Aided Treatments in Parkinson's Disease in Times of COVID-19 889
Trial of Deferiprone in Parkinson's Disease 634
Sex Differences in Parkinson’s Disease: From Bench to Bedside 605
Quantitative gait assessment in Parkinsonian patients with or without Mild Cognitive Impairment 562
Prevalence and associated features of self-reported freezing of gait in Parkinson disease: The DEEP FOG study 554
Cognitive impairment in nondemented Parkinson's disease. 542
Alteration of endosomal trafficking is associated with early-onset parkinsonism caused by SYNJ1 mutations 516
Cognitive dysfunctions and pathological gambling in patients with Parkinson's disease. 512
Success rate, efficacy, and safety/tolerability of overnight switching from immediate- to extended-release pramipexole in advanced Parkinson's disease. 506
Insulin-like growth factor-1 predicts cognitive functions at 2-year follow-up in early, drug-naïve Parkinson's disease. 496
Gender differences in microRNA expression in levodopa-naive PD patients 491
Apparent diffusion coefficient measurements of the middle cerebellar peduncle differentiate the Parkinson variant of MSA from Parkinson's disease and progressive supranuclearpalsy. 481
A simulation tool to plan daily nurse requirements 477
Gait Analysis in Progressive Supranuclear Palsy Phenotypes. 467
Combined regional T1w/T2w ratio and voxel-based morphometry in multiple system atrophy: A follow-up study 453
Cognitive dysfunctions and pathological gambling in patients with Parkinson's disease. Apr 30;24(6):899-905.PMID: 19205072 433
Treatment of nocturnal disturbances and excessive daytime sleepiness in Parkinson's disease. 410
Psychometric properties of the Beck Depression Inventory-II in progressive supranuclear palsy 410
White matter changes and the development of motor phenotypes in de novo Parkinson's Disease 409
Motor and Sensory Features of Cervical Dystonia Subtypes: Data From the Italian Dystonia Registry 408
Quality of Life and Nonmotor Symptoms in Parkinson's Disease 397
Randomized, double-blind, multicenter evaluation of pramipexole extended release once daily in early Parkinson's disease. 394
Default-mode network connectivity in cognitively unimpaired patients with Parkinson disease 391
Rare causes of early-onset dystonia-parkinsonism with cognitive impairment: a de novo PSEN-1 mutation 371
The progression of non-motor symptoms in Parkinson's disease and their contribution to motor disability and quality of life. 361
Neurotransmission in Parkinson's disease: beyond dopamine. 352
Fist-Palm Test (FiPaT): a bedside motor tool to screen for global cognitive status 338
Fist-Palm Test May Identify Mild Cognitive Impairment and Freezing of Gait in Parkinson's Disease: A Machine Learning Approach 325
Effects of Safinamide on Pain in Fluctuating Parkinson's Disease Patients: A Post-Hoc Analysis 312
Energy expenditure, body composition and dietary habits in progressive supranuclear palsy 307
Resting-state brain connectivity in patients with Parkinson's disease and freezing of gait. 286
Bilateral facial palsy after COVID-19 vaccination 285
Improving the Efficacy of Botulinum Toxin for Cervical Dystonia: A Scoping Review 284
Mitochondrial DNA haplogroup K is associated with a lower risk of Parkinson'sdisease in Italians 284
Extended-release pramipexole in advanced Parkinson disease: a randomized controlled trial 268
Clinical and Molecular Characterization of a Novel Progranulin Deletion Associated with Different Phenotypes 267
Magnetic resonance T1w/T2w ratio and voxel-based morphometry in multiple system atrophy 262
Association study between the LINGO1 gene and Parkinson's disease in the Italian population 258
A novel phenotype in an Italian family with a rare progranulin mutation 254
Effect of Global Postural Rehabilitation program on spatiotemporal gait parameters of parkinsonian patients: a three-dimensional motion analysis study. 252
A longitudinal study of cognitive dysfunction in patients affected by Parkinson’s disease with and without freezing of gait 251
Apathy evaluation scale-informant version in progressive supranuclear palsy: Psychometric properties and clinical correlates 250
Validation of the Italian version of Parkinson's Disease-Cognitive Rating Scale (PD-CRS) 237
Relationship Between Orthostatic Hypotension and Cognitive Functions in Multiple System Atrophy: A Longitudinal Study 236
Trial of Cinpanemab in Early Parkinson's Disease 231
Anxiety is associated with striatal dopamine transporter availability in newly diagnosed untreated Parkinson's disease patients. 226
Classifying Different Stages of Parkinson’s Disease Through Random Forests 221
Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's disease 217
Dual-task-related gait patterns as possible marker of precocious and subclinical cognitive alterations in Parkinson disease 212
Hypomorphic NOTCH3 mutation in an Italian family with CADASIL features 211
Metabolomics in Parkinson's disease 203
Intraocular pressure and choroidal thickness postural changes in multiple system atrophy and Parkinson's disease 194
A Bayesian approach to Essential Tremor plus: A preliminary analysis of the TITAN cohort 190
Validation of an Italian version of the 40-item University of Pennsylvania Smell Identification Test that is physician administered: our experience on one hundred and thirty-eight healthy subjects 187
Apoptotic mechanisms in mutant LRRK2-mediated cell death. 186
Lower serum uric acid is associated with mild cognitive impairment in early Parkinson's disease: a 4-year follow-up study 175
Linguistic, psychometric validation and diagnostic ability assessment of an Italian version of a 19-item wearing-off questionnaire for wearing-off detection in Parkinson's disease. 168
Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson's disease patients 165
Imaging of dopaminergic dysfunction with [123I]FP-CIT SPECT in early-onset parkindisease 164
Patient-reported convenience of once-daily versus three-times-daily dosing during long-term studies of pramipexole in early and advanced Parkinson's disease. 164
MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy. 159
Validation of the Italian version of carers’ quality-of-life questionnaire for parkinsonism (PQoL Carer) in progressive supranuclear palsy 158
Personality in Parkinson's disease: Clinical, behavioural and cognitive correlates 157
Anxiety in early Parkinson's disease: Validation of the Italian observer-rated version of the Parkinson Anxiety Scale (OR-PAS) 149
Olfaction in Homozygous and Heterozygous SYNJ1 Arg258Gln Mutation Carriers 149
A neuropsychological longitudinal study in Parkinson's patients with and without hallucinations. 145
Measurements of Postural Sway to Classify Freezing of Gait in Parkinson's Disease 142
Apathy in untreated, de novo patients with Parkinson’s disease: validation study of Apathy Evaluation Scale 141
Accuracy of clinical diagnostic criteria for Friedreich'sataxia. 134
Cognitive performances and DAT imaging in early Parkinson's disease with mild cognitive impairment: a preliminary study 133
Default-mode network connectivity in cognitively unimpaired patients with Parkinson disease 132
Neuropsychological correlates of Pisa syndrome in patients with Parkinson's disease 131
Progression of multiple system atrophy (MSA): a prospective natural history studyby the European MSA Study Group (EMSA SG) 130
Cerebellar ataxia associated with subclinical celiac disease responding togluten-free diet 130
Machine learning can detect the presence of Mild cognitive impairment in patients affected by Parkinson’s Disease 130
Application of the mPSPRS to the Salerno Cohort and a Comparison Between PSP-RS and vPSP 129
Adherence to anti-Parkinson drug therapy in the ?REASON? sample of Italian patients with Parkinson?s disease: the linguistic validation of the Italian version of the ?Morisky Medical Adherence scale-8 items? 124
The natural history of multiple system atrophy: A prospective European cohort study 122
The metric properties of a novel non-motor symptoms scale for Parkinson's disease: Results from an international pilot study. 121
Normative data for the Montreal Cognitive Assessment in an Italian population sample 121
The PRIAMO study: background, methods and recruitment. Apr;29(2):61-5. .PMID: 18483702 119
Increased bilirubin levels in de novo Parkinson's disease 119
Are granular osmiophilic material deposits an epiphenomenon in CADASIL? 119
Affective theory of mind in patients with Parkinson's disease: comment 118
Toward the premotor diagnosis of Parkinson's disease: Suggestions from a modelling study 117
Serum miR-30c-5p is a potential biomarker for multiple system atrophy 117
Mild Cognitive Impairment in newly diagnosed Parkinson's disease: A longitudinal prospective study 117
Prevalence of nonmotor symptoms in Parkinson's disease in an international setting; study using nonmotor symptoms questionnaire in 545 patients. 115
Nonmotor predictors for levodopa requirement in de novo patients with Parkinson's disease 115
Axial motor clues to identify atypical parkinsonism: A multicentre European cohort study 115
A two-year follow-up study of executive dysfunctions in parkinsonian patients with freezing of gait at on-state. 114
Efficacy of rasagiline in patients with the parkinsonian variant of multiple system atrophy: A randomised, placebo-controlled trial 113
Link between non-motor symptoms and cognitive dysfunctions in de novo, drug-naive PD patients. 113
The "gender factor" in wearing-off among patients with parkinson's disease: A post hoc analysis of DEEP study 112
A Four-Year Longitudinal Study on Restless Legs Syndrome in Parkinson Disease 112
Serum uric acid is associated with apathy in early, drug-naïve Parkinson’s disease 112
Long-term safety of rivastigmine in parkinson disease dementia: An open-label, randomized study 110
Totale 28.279
Salva come PNG Salva come JPEG
Categoria #
all - tutte 165.541
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 165.541
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.373 0 0 270 10 363 136 344 19 305 22 341 563
2021/20222.615 14 4 14 25 23 16 40 112 405 368 356 1.238
2022/20234.002 472 174 97 355 656 927 20 382 628 18 187 86
2023/20242.059 159 310 110 162 100 197 86 131 71 138 175 420
2024/20256.305 260 60 145 369 216 669 731 686 911 692 741 825
2025/202624.111 4.870 11.165 8.076 0 0 0 0 0 0 0 0 0
Totale 55.146